Direkt zum Inhalt | Direkt zur Navigation



Molitor, Ernst; Appenrodt, B.; Lehmann, L.E.; Thyssen, L.; Gentemann, M.; Rabe, C.; Trebicka, J.; Stüber, F.; Sauerbruch, T.: Is detection of bacterial DNA in ascitic fluid of clinical relevance? In: European Journal of Gastroenterology and Hepatology, 22, 2010, S. 1487-1494

Molitor, Ernst; Prusseit, J.; Simon, M.; von der Brelie, C.; Heep, A.; Volz, S.; Simon, A.: Epidemiology, prevention and management of ventriculoperitoneal shunt infections in children. In: Pediatric Neurosurgery, 45, 2009, S. 325-336

Molitor, Ernst; Orlopp, K.; von Lilienfeld-Toal, M.; Marklein, G.; Reiffert, S.M.; Welter, A.; Hahn-Ast, C.; Purr, I.; Gorschlüter, M.; Glasmacher, A.: False positivity of the Aspergillus galactomannan Platelia ELISA because of piperacillin/tazobactam treatment: does it represent a clinical problem? In: Journal of Antimicrobial Chemotherapy, 62, 2008, S. 1109-1112

Molitor, Ernst; Simon, A.; Lehrnbecher, T.; Bode, U.; Groll, A.H.; Tramsen, L.; Wieland, R.; Fleischhack, G.; Laws, H.J.: Piperacillin-tazobactam in pediatric cancer patients younger than 25 months: a retrospective multicenter survey. In: European Journal of Clinical Microbiology and Infectious Diseaeses, 26, 2007, S. 801-806

Molitor, Ernst; Tasci, S.; Glasmacher, A.; Lentini, S.; Tschubel, K.; Ewig, S.; Sauerbruch, T.; Lüderitz, B.; Rabe, C.: Pseudomembranous and obstructive Aspergillus tracheobronchitis - optimal diagnostic strategy and outcome. In: Mycoses, 49, 2006, S. 37-42